Výsledky vyhledávání - "Edouard Voznyi"

Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

Autor: Lucile Awad, Sergei Tjulandin, Miguel Fodor, Eric Van Cutsem, Edouard Voznyi, Vladimir Moiseyenko, Manuel Constenla, Corrado Boni, Yee Chao, Jaffer A. Ajani, Alejandro Majlis, Adriano Rodrigues

Publikováno v: Journal of Clinical Oncology. 25:3210-3216

Purpose Therapy of patients with advanced gastric or gastroesophageal junction cancer should provide symptom relief and improve quality of life (QOL) because most patients are symptomatic at baseline. Using validated instruments, we prospectively ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12091fe1f5747770adf3ac5e250faf22
https://doi.org/10.1200/jco.2006.08.3956

Zobrazit plný text záznamu

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Autor: Manuel Constenla, Yee Chao, Vladimir M. Moiseyenko, Adriano Rodrigues, Corrado Boni, Alejandro Majlis, Sergei Tjulandin, Edouard Voznyi, Marie Laure Risse, Eric Van Cutsem, Miguel Fodor, Jaffer A. Ajani

Publikováno v: Journal of Clinical Oncology. 24:4991-4997

Purpose In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be68b0d551c71d94b029cbb99b8a33aa
https://doi.org/10.1200/jco.2006.06.8429

Zobrazit plný text záznamu

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Autor: Els Vercammen, Vladimir Semiglazov, M. Pawlicki, Xiangyang Liu, Sergei Tjulandin, M. Biakhov, David Dodwell, Konstantinas Valuckas, George M. Manikhas, Anton Roth, Edouard Voznyi, José Baselga, Tadeusz Pienkowski, Antoly Makhson, Brian Leyland-Jones

Publikováno v: Journal of Clinical Oncology. 23:5960-5972

Purpose To evaluate the effect on survival and quality of life of maintaining hemoglobin (Hb) in the range of 12 to 14 g/dL with epoetin alfa versus placebo in women with metastatic breast cancer (MBC) receiving first-line chemotherapy. Patients and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aabaa930c2c4a78e373e014985f9c001
https://doi.org/10.1200/jco.2005.06.150

Zobrazit plný text záznamu

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

Autor: Vladimir Moiseyenko, Sergei Tjulandin, Edouard Voznyi, Yee Chao, Jaffer A. Ajani, Cindy Marabotti, Alejandro Majlis, Eric Van Cutsem, Manuel Constenla, Adriano Rodrigues, Corrado Boni, Miguel Fodor

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(22)

Purpose For patients with advanced gastric or gastroesophageal cancer (AGGEC) providing clinical benefit with improved palliation is highly desirable. However, a prospective evaluation of clinical benefit in AGGEC patients has never before been repor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dad0af02197e1ad8e2c640fa57f8908
https://pubmed.ncbi.nlm.nih.gov/18253105

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání